HLA-G Expression Is an Independent Predictor for Improved Survival in High Grade Ovarian Carcinomas

Table 2

Correlation of HLA-A, HLA-B/C, HLA-G, and HLA-E expression with clinical parameters.

	HLA-A			HLA-B/C			HLA-E			HLA-G
	Normal; expression	Downregulation	𝑃	Normal; expression	Downregulation	𝑃	Upregulation	Normal; expression	𝑃	Upregulation	Normal; expression	𝑃
𝑁 (%)	51 (36)	91 (64)		29 (17)	124 (83)		124 (83)	28 (17)		81 (53)	71 (47)
Variables
Age
<60	30	42	0.15	14	63	0.78	65	10	0.26	40	38	0.61
>60	21	49		12	61		59	15		33	41
FIGO stage
Stages I-IIA	4	4	0.39	1	6	0.83	5	2	0.39	3	3	0.87
Stage >IIB	47	87		25	118		119	23		78	68
Residual tumor
No residual	18	14	0.006	11	22	0.006	27	4	0.51	23	10	0.033
Any residual	33	77		15	102		97	21		58	61
Platinum sensitivity
Resistant	15	40	0.08	9	48	0.66	52	9	0.66	25	35	0.014
Sensitive	33	46		15	65		66	14		53	32